Genome-wide expression for diagnosis of pulmonary tuberculosis: A multicohort analysis

The Lancet Respiratory Medicine

Volumn 4, Issue 3, 2016, Pages 213-224

  Sweeney, Timothy E ^a,b   Braviak, Lindsay ^a   Tato, Cristina M ^a   Khatri, Purvesh ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; BCG VACCINATION; COHORT ANALYSIS; CONTROLLED STUDY; DUSP3 GENE; GBP5 PROTEIN; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; KLF2 GENE; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; TREATMENT RESPONSE; TUBERCULOSIS; BLOOD; DNA MICROARRAY; GENETIC DATABASE; GENETICS; GENOME-WIDE ASSOCIATION STUDY; INFORMATION PROCESSING; META ANALYSIS; TUBERCULOSIS, PULMONARY; VALIDATION STUDY;

DUAL SPECIFICITY PHOSPHATASE 3; DUSP3 PROTEIN, HUMAN; GBP5 PROTEIN, HUMAN; GUANINE NUCLEOTIDE BINDING PROTEIN; KLF2 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR;

AREA UNDER CURVE; COHORT STUDIES; DATABASES, GENETIC; DATASETS AS TOPIC; DUAL SPECIFICITY PHOSPHATASE 3; GENE EXPRESSION; GENOME-WIDE ASSOCIATION STUDY; GTP-BINDING PROTEINS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LATENT TUBERCULOSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ROC CURVE; TUBERCULOSIS, PULMONARY;

EID: 84959505947     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(16)00048-5     Document Type: Article

References (43)

1. Global tuberculosis report 2015, Global Tuberculosis Programme, WHOWHO, World Health Organisation, Geneva.
2. Wallis RS, Pai M, Menzies D, et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 2010, 375:1920-1937.
3. Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2014, 1. CD009593.
4. Friedrich SO, Rachow A, Saathoff E, et al. Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment. Lancet Respir Med 2013, 1:462-470.
5. High-priority target product profiles for new tuberculosis diagnostics: report of a consensus meeting 2014, WHO, World Health Organization, Geneva.
6. Anderson ST, Kaforou M, Brent AJ, et al. Diagnosis of childhood tuberculosis and host RNA expression in Africa. N Engl J Med 2014, 370:1712-1723.
7. Kaforou M, Wright VJ, Oni T, et al. Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study. PLoS Med 2013, 10:e1001538.
8. Berry MP, Graham CM, McNab FW, et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010, 466:973-977.
9. Bloom CI, Graham CM, Berry MP, et al. Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers. PLoS One 2013, 8:e70630.
10. Verhagen LM, Zomer A, Maes M, et al. A predictive signature gene set for discriminating active from latent tuberculosis in Warao Amerindian children. BMC Genomics 2013, 14:74.
11. Laux da Costa L, Delcroix M, Dalla Costa ER, et al. A real-time PCR signature to discriminate between tuberculosis and other pulmonary diseases. Tuberculosis (Edinb) 2015, 95:421-425.
12. Maertzdorf J, McEwen G, Weiner J, et al. Concise gene signature for point-of-care classification of tuberculosis. EMBO Mol Med 2015, published online Dec 18. 10.15252/emmm.201505790.
13. Cliff JM, Lee JS, Constantinou N, et al. Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response. J Infect Dis 2013, 207:18-29.
14. Wu Z, Irizarry R, Gentleman R, Martinez-Murillo F, Spencer F A model-based background adjustment for oligonucleotide expression arrays. J Am Sta Assoc 2004, 99:909-917.
15. Smyth G Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions Using R and Bioconductor 2005, 397-420. Springer, New York. R.C.V. Gentleman, S. Dudoit, R. Irizarry, W. Huber (Eds.).
16. Khatri P, Roedder S, Kimura N, et al. A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation. J Exp Med 2013, 210:2205-2221.
17. Sweeney TE, Shidham A, Wong HR, Khatri P A comprehensive time-course-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set. Sci Transl Med 2015, 7:287ra71.
18. Li MD, Burns TC, Morgan AA, Khatri P Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases. Acta Neuropathol Commun 2014, 2:93.
19. Andres-Terre M, McGuire H, Pouliot Y, Sweeney T, Tato C, Khatri P Transcriptional signatures of viral infection across multiple respiratory viruses derived from integrated, multi-cohort analysis. Immunity 2015, 43:1199-1211.
20. Youden WJ Index for rating diagnostic tests. Cancer 1950, 3:32-35.
21. Kester AD, Buntinx F Meta-analysis of ROC curves. Med Decis Making 2000, 20:430-439.
22. Maertzdorf J, Ota M, Repsilber D, et al. Functional correlations of pathogenesis-driven gene expression signatures in tuberculosis. PLoS One 2011, 6:e26938.
23. Ottenhoff TH, Dass RH, Yang N, et al. Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis. PLoS One 2012, 7:e45839.
24. Maertzdorf J, Weiner J, Mollenkopf HJ, et al. Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proc Natl Acad Sci U S A 2012, 109:7853-7858.
25. Bloom CI, Graham CM, Berry MP, et al. Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy. PLoS One 2012, 7:e46191.
26. Wu LS, Lee SW, Huang KY, Lee TY, Hsu PW, Weng JT Systematic expression profiling analysis identifies specific microRNA-gene interactions that may differentiate between active and latent tuberculosis infection. Biomed Res Int 2014, 2014:895179.
27. Cai Y, Yang Q, Tang Y, et al. Increased complement C1q level marks active disease in human tuberculosis. PLoS One 2014, 9:e92340.
28. Dawany N, Showe LC, Kossenkov AV, et al. Identification of a 251 gene expression signature that can accurately detect M. tuberculosis in patients with and without HIV co-infection. PLoS One 2014, 9:e89925.
29. Tientcheu LD, Maertzdorf J, Weiner J, et al. Differential transcriptomic and metabolic profiles of M africanum- and M tuberculosis-infected patients after, but not before, drug treatment. Genes Immun 2015, 16:347-355.
30. Maertzdorf J, Repsilber D, Parida SK, et al. Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun 2011, 12:15-22.
31. Maji A, Misra R, Kumar Mondal A, et al. Expression profiling of lymph nodes in tuberculosis patients reveal inflammatory milieu at site of infection. Sci Rep 2015, 5:15214.
32. Denkinger CM, Kik SV, Cirillo DM, et al. Defining the needs for next generation assays for tuberculosis. J Infect Dis 2015, 211:S29-S38.
33. Jiang L, Mancuso M, Lu Z, Akar G, Cesarman E, Erickson D Solar thermal polymerase chain reaction for smartphone-assisted molecular diagnostics. Sci Rep 2014, 4:4137.
34. Temple R Enrichment of clinical study populations. Clin Pharmacol Ther 2010, 88:774-778.
35. Roadmap for Rolling Out Xpert MTB/RIF for Rapid Diagnosis of TB and MDR-TB 2010, WHO, Worltd Health Organization, Geneva.
36. Dorhoi A, Kaufmann SH Perspectives on host adaptation in response to Mycobacterium tuberculosis: modulation of inflammation. Semin Immunol 2014, 26:533-542.
37. Shenoy AR, Wellington DA, Kumar P, et al. GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals. Science 2012, 336:481-485.
38. Meunier E, Wallet P, Dreier RF, et al. Guanylate-binding proteins promote activation of the AIM2 inflammasome during infection with Francisella novicida. Nat Immunol 2015, 16:476-484.
39. Ishibashi T, Bottaro DP, Chan A, Miki T, Aaronson SA Expression cloning of a human dual-specificity phosphatase. Proc Natl Acad Sci USA 1992, 89:12170-12174.
40. Alonso A, Saxena M, Williams S, Mustelin T Inhibitory role for dual specificity phosphatase VHR in T cell antigen receptor and CD28-induced Erk and Jnk activation. J Biol Chem 2001, 276:4766-4771.
41. Mahabeleshwar GH, Qureshi MA, Takami Y, Sharma N, Lingrel JB, Jain MK A myeloid hypoxia-inducible factor 1α-Krüppel-like factor 2 pathway regulates gram-positive endotoxin-mediated sepsis. J Biol Chem 2012, 287:1448-1457.
42. Das M, Lu J, Joseph M, et al. Kruppel-like factor 2 (KLF2) regulates monocyte differentiation and functions in mBSA and IL-1β-induced arthritis. Curr Mol Med 2012, 12:113-125.
43. Lingrel JB, Pilcher-Roberts R, Basford JE, et al. Myeloid-specific Krüppel-like factor 2 inactivation increases macrophage and neutrophil adhesion and promotes atherosclerosis. Circ Res 2012, 110:1294-1302.